Steven W Weldon insider trades: GT Biopharma (GTBP) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Steven reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 22, 2020 | GTBP | ↓ Sell | 183,700 | $0.34 | $63K | Direct | Dec 23, 2020 (1d) |
| Dec 18, 2020 | GTBP | ↓ Sell | 200,000 | $0.30 | $61K | Direct | Dec 18, 2020 (0d) |
| Dec 15, 2020 | GTBP | ↓ Sell | 396,300 | $0.29 | $113K | Direct | Dec 15, 2020 (0d) |
| May 13, 2020 | GTBP | ↓ Sell | 2,269,708 | $0.00 | $2K | Direct | May 14, 2020 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Steven W Weldon's insider trades
Steven W Weldon is an insider at GT Biopharma (GTBP). Since May 13, 2020, Steven has reported no open-market purchases and 4 sales worth $239K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every GTBP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.